1.155
price up icon5.00%   0.055
after-market Handel nachbörslich: 1.11 -0.045 -3.90%
loading
Schlusskurs vom Vortag:
$1.10
Offen:
$1.07
24-Stunden-Volumen:
858.38K
Relative Volume:
0.48
Marktkapitalisierung:
$187.61M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
28.88
EPS:
0.04
Netto-Cashflow:
$146.36M
1W Leistung:
-12.50%
1M Leistung:
+43.55%
6M Leistung:
-25.00%
1J Leistung:
-75.21%
1-Tages-Spanne:
Value
$1.07
$1.16
1-Wochen-Bereich:
Value
$1.01
$1.3488
52-Wochen-Spanne:
Value
$0.5271
$5.1288

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Firmenname
Ironwood Pharmaceuticals Inc
Name
Telefon
617-621-7722
Name
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Mitarbeiter
253
Name
Twitter
@ironwoodpharma
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
IRWD's Discussions on Twitter

Vergleichen Sie IRWD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
IRWD
Ironwood Pharmaceuticals Inc
1.155 178.68M 400.57M 9.21M 146.36M 0.04
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.32 67.90B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.40 48.29B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.80 44.04B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.95 21.20B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
400.52 17.21B 2.99B 1.21B 1.13B 25.06

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Herabstufung Jefferies Buy → Hold
2025-04-15 Herabstufung Wells Fargo Overweight → Equal Weight
2025-04-14 Herabstufung Citizens JMP Mkt Outperform → Mkt Perform
2024-09-09 Eingeleitet Leerink Partners Market Perform
2024-08-08 Herabstufung CapitalOne Overweight → Equal Weight
2024-01-17 Eingeleitet Craig Hallum Buy
2023-12-14 Eingeleitet Wells Fargo Overweight
2023-11-09 Eingeleitet Jefferies Buy
2023-09-28 Eingeleitet JMP Securities Mkt Outperform
2022-09-02 Eingeleitet CapitalOne Overweight
2022-04-22 Eingeleitet Piper Sandler Overweight
2020-09-30 Herabstufung Wells Fargo Overweight → Equal Weight
2020-06-17 Eingeleitet Northland Capital Outperform
2019-07-10 Fortgesetzt Credit Suisse Neutral
2019-03-27 Hochstufung Morgan Stanley Underweight → Equal-Weight
2019-02-25 Hochstufung H.C. Wainwright Sell → Neutral
2019-01-24 Hochstufung JP Morgan Underweight → Neutral
2018-11-07 Herabstufung Credit Suisse Outperform → Neutral
2018-11-07 Herabstufung JP Morgan Neutral → Underweight
2018-07-23 Eingeleitet H.C. Wainwright Sell
2018-05-09 Herabstufung Morgan Stanley Equal-Weight → Underweight
2018-01-05 Herabstufung BofA/Merrill Buy → Underperform
2017-12-06 Herabstufung Mizuho Buy → Neutral
2017-07-21 Herabstufung JP Morgan Overweight → Neutral
2017-05-03 Eingeleitet Wells Fargo Outperform
2017-04-07 Bestätigt Mizuho Buy
2017-02-22 Bestätigt Barclays Equal Weight
2016-11-04 Bestätigt Mizuho Buy
2016-10-24 Bestätigt Wedbush Neutral
2016-10-10 Bestätigt Mizuho Buy
2016-09-27 Bestätigt WallachBeth Hold
Alle ansehen

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

pulisher
Sep 06, 2025

What are Ironwood Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Technicals & Technical Entry and Exit Tips - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Is Ironwood Pharmaceuticals Inc. likely to announce a buybackJuly 2025 Gainers & AI Powered Market Entry Strategies - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

Is Ironwood Pharmaceuticals Inc. stock a good pick for beginnersJuly 2025 Sector Moves & Intraday High Probability Setup Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

When is the best time to exit Ironwood Pharmaceuticals Inc.Weekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Comparing Ironwood Pharmaceuticals Inc. in custom built stock radarsQuarterly Trade Report & Safe Entry Zone Tips - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Using Ichimoku Cloud for Ironwood Pharmaceuticals Inc. technicalsMarket Sentiment Report & Daily Momentum Trading Reports - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Combining price and volume data for Ironwood Pharmaceuticals Inc.2025 Trading Recap & Daily Stock Trend Reports - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Measuring Ironwood Pharmaceuticals Inc.’s beta against major indicesMarket Activity Report & Safe Entry Momentum Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can Ironwood Pharmaceuticals Inc. recover in the next quarter2025 Price Targets & Long Hold Capital Preservation Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How hedge fund analytics apply to Ironwood Pharmaceuticals Inc. stock2025 Key Lessons & Weekly Top Gainers Trade List - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Why Did Ironwood Pharmaceuticals Stock Plunge 17.74%? - AInvest

Sep 04, 2025
pulisher
Sep 03, 2025

Is Ironwood Pharmaceuticals Inc. reversing from oversold territoryJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Earnings visualization tools for Ironwood Pharmaceuticals Inc.Watch List & Stepwise Entry and Exit Trade Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Ironwood Pharmaceuticals Inc.’s growth already priced inWeekly Stock Report & Safe Entry Momentum Tips - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Should you hold or exit Ironwood Pharmaceuticals Inc. now2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ironwood Pharma Regains Nasdaq Compliance - TipRanks

Sep 03, 2025
pulisher
Sep 03, 2025

Will Ironwood Pharmaceuticals Inc. benefit from rate cutsJuly 2025 Update & Free Risk Controlled Daily Trade Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Ironwood Pharmaceuticals Inc. stock trendline breakdownQuarterly Profit Report & Long-Term Investment Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 06:20:24 - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Published on: 2025-09-03 04:31:42 - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Ironwood Pharmaceuticals Inc. stock chart pattern explainedEarnings Summary Report & Risk Managed Investment Signals - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Ironwood Pharmaceuticals Inc. stock entering bullish territoryMarket Sentiment Review & Weekly Hot Stock Watchlists - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Will Ironwood Pharmaceuticals Inc. stock recover after recent drop2025 Winners & Losers & Risk Managed Investment Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 07:32:33 - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Using data models to predict Ironwood Pharmaceuticals Inc. stock movementWeekly Profit Analysis & Technical Confirmation Alerts - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

What indicators show strength in Ironwood Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Safe Entry Zone Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What Fibonacci levels say about Ironwood Pharmaceuticals Inc. reboundExit Point & AI Driven Price Predictions - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 13:49:26 - beatles.ru

Aug 31, 2025
pulisher
Aug 30, 2025

RSI Reset May Fuel Rebound in Ironwood Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 30, 2025
pulisher
Aug 30, 2025

Risk adjusted return profile for Ironwood Pharmaceuticals Inc. analyzedPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Options Data Show Bullish Bias in Ironwood Pharmaceuticals Inc.July 2025 Rallies & Safe Entry Trade Reports - beatles.ru

Aug 30, 2025
pulisher
Aug 29, 2025

Analysts Spot Bullish Divergence in Ironwood Pharmaceuticals Inc.2025 Stock Rankings & Safe Capital Preservation Plans - beatles.ru

Aug 29, 2025
pulisher
Aug 29, 2025

Analyzing drawdowns of Ironwood Pharmaceuticals Inc. with statistical toolsInsider Buying & Low Risk Entry Point Guides - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Published on: 2025-08-29 17:20:59 - Newser

Aug 29, 2025

Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$29.94
price up icon 3.53%
$18.43
price up icon 5.50%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.34%
$10.50
price up icon 1.65%
$144.10
price up icon 2.64%
$400.52
price up icon 5.27%
Kapitalisierung:     |  Volumen (24h):